At meeting held on 15 December 2017
The Board of Aarey Drugs & Pharmaceuticals at its meeting held on 15 December 2017 approved raising of funds by way of issue of equity shares by way of QIP issue for an aggregate amount of Rs 30 crore and /or convertible warrants aggregating up to Rs 10 crore on preferential basis. The Board also approved resignation of Lalit Tulsiani as the Director of the Company.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
